Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-09T21:54:59.811Z Has data issue: false hasContentIssue false

Epidemiological investigation of recurrent outbreaks of haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli serotype O55:H7 in England, 2014–2018

Published online by Cambridge University Press:  19 April 2021

C. Sawyer
Affiliation:
Health Protection Division, Public Health Wales, Tyndall Street, Cardiff CF10 4BZ, UK Field Services, National Infection Service, Public Health England, London, UK
B. Vishram
Affiliation:
National Infections Service, Public Health England, 61 Colindale Ave, London NW9 5HT, UK
C. Jenkins*
Affiliation:
National Infections Service, Public Health England, 61 Colindale Ave, London NW9 5HT, UK
F. Jorgensen
Affiliation:
Public Health England Food Water and Environmental Microbiology Laboratory Porton, Salisbury SP4 0JG, UK
L. Byrne
Affiliation:
National Infections Service, Public Health England, 61 Colindale Ave, London NW9 5HT, UK
A. F. W. Mikhail
Affiliation:
National Infections Service, Public Health England, 61 Colindale Ave, London NW9 5HT, UK
T. J. Dallman
Affiliation:
National Infections Service, Public Health England, 61 Colindale Ave, London NW9 5HT, UK
K. Carroll
Affiliation:
PHE South East, Surrey and Sussex HPT, Parkside, Chart Way, Horsham RH12 1XA, UK
L. Ahyow
Affiliation:
East Midlands Health Protection Team, Public Health England, Nottingham NG2 4LA, UK
Q. Vahora
Affiliation:
PHE South East, Surrey and Sussex HPT, Parkside, Chart Way, Horsham RH12 1XA, UK
G. Godbole
Affiliation:
National Infections Service, Public Health England, 61 Colindale Ave, London NW9 5HT, UK
S. Balasegaram
Affiliation:
Field Services, National Infection Service, Public Health England, London, UK
*
Author for correspondence: C. Jenkins, E-mail: claire.jenkins@phe.gov.uk
Rights & Permissions [Opens in a new window]

Abstract

Recurrent outbreaks of haemolytic uraemic syndrome (HUS) caused by Shiga toxin-producing Escherichia coli (STEC) serotype O55:H7 occurred in England between 2014 and 2018. We reviewed the epidemiological evidence to identify potential source(s) and transmission routes of the pathogen, and to assess the on-going risk to public health. Over the 5-year period, there were 43 confirmed and three probable cases of STEC O55:H7. The median age of cases was 4 years old (range 6 months to 69 years old) and over half of all cases were female (28/46, 61%). There were 36/46 (78.3%) symptomatic cases, and over half of all cases developed HUS (25/46, 54%), including two fatal cases. No common food or environmental exposures were identified, although the majority of cases lived in rural or semi-rural environments and reported contact with both wild and domestic animals. This investigation informed policy on the clinical and public health management of HUS caused by STEC other than serotype O157:H7 (non-O157 STEC) in England, including comprehensive testing of all household contacts and household pets and more widespread use of polymerase chain reaction assays for the rapid diagnosis of STEC-HUS.

Information

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press
Figure 0

Fig. 1. Epidemiological curve showing cases of STEC O55:H7 in England by month and year of onset, 2014–2018.

Figure 1

Fig. 2. Age/sex pyramid of all cases of STEC O55:H7 in England, 2014–2018.

Figure 2

Fig. 3. Map showing the geographical distribution of cases.

Figure 3

Table 1. Description of STEC O55:H7 cases, 2014–2018

Figure 4

Fig. 4. Phylogenetic tree showing the relationship between STEC O55:H7 linked to the recurrent outbreaks of in England between 2014 and 2018. All isolates were from human cases unless otherwise stated. Each sample is labelled by location, year of isolation and short read accession number. ROI – Republic of Ireland. *designated as a sporadic case.

Figure 5

Table 2. Characteristics and clinical symptoms of STEC O55:H7 cases (confirmed and probable) by outbreak, 2014–2018

Figure 6

Table 3. Odds of developing symptoms: STEC O55:H7 Stx2a eae  + ve compared to STEC O157:H7 Stx2a eae  + ve

Figure 7

Table 4. Summary of exposures of cases of STEC O55:H7 from enhanced ESQs